AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function
Recruiting
N/A
Interventional Study
Atrial Fibrillation
Atrial Arrhythmia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 86 (estimated)
- Sponsor
- St. Josefs-Hospital Wiesbaden GmbH · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
AVA CONDUCT is a prospective, multicenter, randomized study with single blinding, comparing left bundle branch area (LBBA) pacing with right ventricular (RV) pacing following AV node ablation in terms of clinical, functional, and electrophysiological outcomes.
The primary hypothesis is that pacing-induced cardiomyopathy, defined as a decrease in LVEF by 10% or more from baseline to an absolute va…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. History of symptomatic AF (EHRA IIb - IV) despite guideline-indicated medical or interventional therapy
2. Preserved LVEF (≥ 50%, assessed by echocardiography, Simpson's biplane method)
3. AV node ablation scheduled independently of possible study participation
4. Age ≥ 18 ye…
Contacts
No contact information available.